Rabaca, Baby Boy .
HRN: 29-12-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
AMPICILLIN 500MG (VIAL)
06/05/2026
06/12/2026
IV
95mg
Q12H
NAMF (maternal UTI)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes